ETFs Omnicell, Inc.

OMCL

US68213N1090

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 09:58:11 2026-10-29 EDT			5-day change	1st Jan Change
37.90 ^USD	+5.44%		-0.38%	-18.41%

08:23am	Omnicell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
07:19am	(OMCL) Omnicell, Inc. Expects Q4 Revenue Range $295.0M - $301.0M	MT

ETFs positioned on Omnicell, Inc.

Name	YTD change	Weight	AuM
FIRST TRUST SMALL CAP CORE ALPHADEX FUND ETF - USD	+23.26%	-	1,411 M€
INVESCO S&P SMALLCAP 600 REVENUE ETF - USD	+20.65%	-	2,098 M€
STATE STREET SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF - USD	+15.50%	-	5,739 M€
GLOBAL X TELEMEDICINE & DIGITAL HEALTH UCITS ETF DIST - USD	+26.62%	3.18%	0 M€
GLOBAL X TELEMEDICINE & DIGITAL HEALTH UCITS ETF - USD	+25.81%	2.06%	6 M€
STATE STREET SPDR S&P HEALTH CARE EQUIPMENT ETF - USD	+7.17%	2.05%	176 M€
GLOBAL X TELEMEDICINE & DIGITAL HEALTH ETF - USD	+7.96%	1.58%	31 M€
INVESCO S&P SMALLCAP HEALTH CARE ETF - USD	+27.32%	1.28%	184 M€
L&G HEALTHCARE TECHNOLOGY & INNOVATION UCITS ETF - USD	+31.23%	1.16%	303 M€
GLOBAL X ROBOTICS & ARTIFICIAL INTELLIGENCE UCITS ETF (DIST) - USD	-5.37%	0.77%	20 M€
RESEARCH AFFILIATES DELETIONS ETF - USD	+32.99%	0.68%	42 M€
GLOBAL X ROBOTICS & ARTIFICIAL INTELLIGENCE UCITS ETF (ACC) - USD	-1.35%	0.66%	149 M€
GLOBAL X ROBOTICS & AI INDEX ETF - CAD HEDGED	-7.96%	0.61%	54 M€
GLOBAL X ROBOTICS & ARTIFICIAL INTELLIGENCE ETF - USD	-8.20%	0.55%	3,586 M€
VANECK GENOMICS AND HEALTHCARE INNOVATORS UCITS ETF - USD	+39.28%	0.51%	15 M€
FIRST TRUST NASDAQ ARTIFICIAL INTELLIGENCE AND ROBOTICS ETF - USD	+12.02%	0.41%	779 M€
INVESCO NASDAQ FUTURE GEN 200 ETF - USD	+20.57%	0.4%	23 M€
FIRST TRUST SMALL CAP VALUE ALPHADEX FUND ETF - USD	+22.35%	0.35%	200 M€
FIDELITY ENHANCED SMALL CAP ETF - USD	+22.18%	0.33%	6,480 M€
STATE STREET SPDR S&P 600 SMALL CAP VALUE ETF - USD	+16.87%	0.28%	5,092 M€
FIRST TRUST ACTIVE FACTOR SMALL CAP ETF - USD	+22.14%	0.25%	123 M€
STATE STREET SPDR S&P KENSHO NEW ECONOMIES COMPOSITE ETF - DISTRIBUTING - USD	+7.68%	0.25%	2,826 M€
VANGUARD S&P SMALL-CAP 600 VALUE ETF - USD	+17.26%	0.24%	1,900 M€
ISHARES S&P SMALL-CAP 600 VALUE ETF - USD	+17.28%	0.21%	8,373 M€
AVANTIS U.S. SMALL CAP EQUITY ETF - USD	+21.98%	0.19%	3,154 M€
JPMORGAN DIVERSIFIED RETURN U.S. SMALL CAP EQUITY ETF (D) - USD	+16.03%	0.19%	605 M€
ISHARES U.S. MEDICAL DEVICES ETF - USD	-11.15%	0.17%	3,478 M€
AMUNDI S&P SMALLCAP 600 SCREENED UCITS ETF DIST - USD	+19.58%	0.16%	156 M€
ISHARES US MEDICAL DEVICES UCITS ETF (ACC) - USD	-12.65%	0.16%	234 M€
ISHARES S&P SMALLCAP 600 UCITS ETF - USD	+20.96%	0.14%	3,276 M€
JPMORGAN FUNDAMENTAL DATA SCIENCE SMALL CORE ETF - USD	+21.47%	0.14%	9 M€

1 2 3 4 5

Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.

Employees

3,485

Sector

Advanced Medical Equipment & Technology

Calendar

09:30am Earnings release - Q3 2026

More about the company